or
forgot password

    • cancer clinical trials in charleston, SC

    • Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
    Charleston Cancer Center
    Charleston, South Carolina 29406
    Cancer Cachexia
    Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    Medical University of South Carolina

    Trial Locations
    Medical University of South Carolina
    Charleston Cancer Center
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    A Safety and Efficacy Study of Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Anesthesia, Surgical Procedures, Elective
    A Safety and Efficacy Study in Patients With Gastric Cancer
    Charleston Cancer Center
    Charleston, South Carolina 29406
    Gastric Cancer
    Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
    Ralph H Johnson VA Medical Center, Charleston
    Charleston, South Carolina 29401-5799
    Rheumatoid Arthritis
    Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx
    BI 2536 Second Line Monotherapy in SCLC
    1216.11.011 Boehringer Ingelheim Investigational Site
    Charleston, South Carolina
    Carcinoma, Small Cell
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Atrial Fibrillation, Atrial Flutter
    Dose/ Schedule Finding Trial of AMG 531 for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
    Research Site
    Charleston, South Carolina
    Lung Cancer, Chemotherapy-Induced Thrombocytopenia, Non-small Cell Lung Cancer, Cancer, Lung Neoplasms, Oncology, Solid Tumors, Thrombocytopenia
    Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
    Site Reference ID/Investigator# 4533
    Charleston, South Carolina 29406
    Rheumatoid Arthritis
    Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell Lymphoma
    Charleston Hematology Oncology Associates, PA
    Charleston, South Carolina 29403
    Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin
    Assessment and Tracking of Long-term Alefacept Safety
    Marta Hampton

    Trial Locations
    Marta Hampton
    Rheumatology Associates
    Psoriasis
    Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877
    Research Site
    Charleston, South Carolina
    Lymphoma, NHL, Non-Hodgkin Lymphoma
    Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Leukemia
    Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib
    Site Reference ID/Investigator# 7300
    Charleston, South Carolina 29425
    Advanced Renal Cell Carcinoma
    Oxidized Glutathione (NOV-002), Doxorubicin, Cyclophosphamide, and Docetaxel in Treating Women With Newly Diagnosed Stage IIB, or Stage IIIC Breast Cancer
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Breast Cancer
    Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Recurrent Glioblastoma Multiforme
    Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Head and Neck Cancer
    Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Leukemia, Myeloid
    Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Acute Myeloid Leukemia
    BIBW 2992 (Afatinib) in Head & Neck Cancer
    1200.28.0013 Boehringer Ingelheim Investigational Site
    Charleston, South Carolina
    Head and Neck Neoplasms, Carcinoma, Squamous Cell
    Endometrial Safety Study

    Charleston, South Carolina
    Postmenopause
    Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Head and Neck Cancer, Precancerous Condition
    A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin
    Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
    Sanofi-Aventis Investigational Site Number 840085
    Charleston, South Carolina 29403
    Colorectal Neoplasms, Neoplasm Metastasis
    Efficacy and Safety of Prochymal™ Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute GVHD
    Medical University of South Carolina(MUSC)
    Charleston, South Carolina 29425
    Graft Versus Host Disease
    Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Cervical Cancer, Endometrial Cancer, Lymphedema, Vulvar Cancer
    A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
    Medical University of South Carolina: Hollings Cancer Center
    Charleston, South Carolina 29425
    Non Small Cell Lung Cancer
    Phase 3 Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant for Noninvasive Bladder Cancer
    Medical University of South Carolina, Dept. of Urology
    Charleston, South Carolina 29425
    Bladder Cancer
    Study of Voreloxin in Older Patients With Untreated Acute Myeloid Leukemia
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Leukemia, Acute Disease, Acute Myeloid Leukemia, Nonlymphocytic Leukemia, Myelodysplastic Syndromes
    Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
    Sanofi-Aventis Investigational Site Number 840052
    Charleston, South Carolina 29406
    Urinary Bladder Neoplasms
    A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
    Research Site
    Charleston, South Carolina
    Adenocarcinoma of the Pancreas, Metastatic Pancreatic Cancer, Pancreatic Cancer
    Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients
    Charleston Hematology Oncology Associates, PA
    Charleston, South Carolina 29403
    Hormone-Refractory Prostate Cancer
    ChemoFx® PRO - A Post-Market Data Collection Study
    Medical University of South Carolina Hospital
    Charleston, South Carolina 29403
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer
    Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Unspecified Childhood Solid Tumor, Protocol Specific
    Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Glioblastoma Multiforme
    Cognition in the Study of Tamoxifen and Raloxifene
    Roper Hospital
    Charleston, South Carolina 29401
    Cognition, Aging
    Improving Clinician Communication Skills (ICCS)
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Advanced Cancer, Chronic Obstructive Pulmonary Disease (COPD), Restrictive Lung Disease, Congestive Heart Failure, End Stage Liver Disease
    APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
    Charleston Hematology Oncology Associates
    Charleston, South Carolina 29403
    Pancreatic Cancer, Metastatic Pancreatic Cancer
    Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Diagnostic Imaging, Central Nervous System Diseases
    Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Head and Neck Cancer
    An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Ovarian Cancer